The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy
Open accessAbstract
BACKGROUND: Sporadic vascular malformations (VMs) are complex congenital anomalies of blood vessels that lead to stroke, life-threatening bleeds, disfigurement, overgrowth, and/or pain. Therapeutic options are severely limited, and multidisciplinary management remains challenging, particularly for high-flow arteriovenous malformations (AVM). METHODS: To investigate the pathogenesis of sporadic intracranial and extracranial VMs in 160 children in which known genetic causes had been excluded, we sequenced DNA from affected tissue and optimized analysis for detection of low mutant allele frequency. RESULTS: We discovered multiple mosaic-activating variants in 4 genes of the RAS/MAPK pathway, KRAS, NRAS, BRAF, and MAP2K1, a pathway commonly activated in cancer and responsible for the germline RAS-opathies. These variants were more frequent in high-flow than low-flow VMs. In vitro characterization and 2 transgenic zebrafish AVM models that recapitulated the human phenotype validated the pathogenesis of the mutant alleles. Importantly, treatment of AVM-BRAF mutant zebrafish with the BRAF inhibitor vemurafinib restored blood flow in AVM. CONCLUSION: Our findings uncover a major cause of sporadic VMs of different clinical types and thereby offer the potential of personalized medical treatment by repurposing existing licensed cancer therapies. FUNDING: This work was funded or supported by grants from the AVM Butterfly Charity, the Wellcome Trust (UK), the Medical Research Council (UK), the UK National Institute for Health Research, the L'Oreal-Melanoma Research Alliance, the European Research Council, and the National Human Genome Research Institute (US).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v10: protein–protein interaction networks, integrated over the tree of life
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436
In Vivo Imaging of Embryonic Vascular Development Using Transgenic Zebrafish
Lawson, N. D., & Weinstein, B. M. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0711 · Cited by 2,151
The Tol2kit: A multisite gateway‐based construction kit for Tol2 transposon transgenesis constructs
Kwan, K. M., Fujimoto, E., Grabher, C., Mangum, B. D., Hardy, M. E., Campbell, D. S., Parant, J. M., Yost, H. J., Kanki, J. P., & Chien, C. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21343 · Cited by 1,774
Wassef, M., Blei, F., Adams, D., Alomari, A., Baselga, E., Berenstein, A., Burrows, P., Frieden, I. J., Garzon, M. C., Lopez-Gutierrez, J.-C., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-3673 · Cited by 1,419
An efficient one-step site-directed and site-saturation mutagenesis protocol
Zheng, L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh110 · Cited by 1,178
Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in GNAQ
Shirley, M. D., Tang, H., Gallione, C. J., Baugher, J. D., Frelin, L. P., Cohen, B., North, P. E., Marchuk, D. A., Comi, A. M., & Pevsner, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213507 · Cited by 1,096
A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome
Lindhurst, M. J., Sapp, J. C., Teer, J. K., Johnston, J. J., Finn, E. M., Peters, K., Turner, J., Cannons, J. L., Bick, D., Blakemore, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104017 · Cited by 903
Self-citationVascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2
Vikkula, M., Boon, L. M., Iii, K. L. C., Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81814-0 · Cited by 802
Finding of Rare Disease Genes (FORGE) Canada Consortium, Rivière, J.-B., Mirzaa, G. M., O'Roak, B. J., Beddaoui, M., Alcantara, D., Conway, R. L., St-Onge, J., Schwartzentruber, J. A., Gripp, K. W., et al. (2012) · Nature Genetics · doi:10.1038/ng.2331 · Cited by 741
Self-citationHapple, R. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)80249-9 · Cited by 552
Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome
Kurek, K. C., Luks, V. L., Ayturk, U. M., Alomari, A. I., Fishman, S. J., Spencer, S. A., Mulliken, J. B., Bowen, M. E., Yamamoto, G. L., Kozakewich, H. P. W., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.006 · Cited by 532
Limaye, N., Wouters, V., Uebelhoer, M., Tuominen, M., Wirkkala, R., Mulliken, J. B., Eklund, L., Boon, L. M., & Vikkula, M. (2009) · Nature Genetics · doi:10.1038/ng.272 · Cited by 492
Mutations within the Programmed Cell Death 10 Gene Cause Cerebral Cavernous Malformations
Bergametti, F., Denier, C., Labauge, P., Arnoult, M., Boetto, S., Clanet, M., Coubes, P., Echenne, B., Ibrahim, R., Irthum, B., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/426952 · Cited by 450
Sahoo, T., Johnson, E. W., Thomas, J. W., Kuehl, P. M., Jones, T. L., Dokken, C. G., Touchman, J. W., Gallione, C. J., Lee-Lin, S.-Q., Kosofsky, B., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2325 · Cited by 382
Kinsler, V. A., Thomas, A. C., Ishida, M., Bulstrode, N. W., Loughlin, S., Hing, S., Chalker, J., McKenzie, K., Abu-Amero, S., Slater, O., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.70 · Cited by 348
Self-citationLiquori, C. L., Berg, M. J., Siegel, A. M., Huang, E., Zawistowski, J. S., Stoffer, T., Verlaan, D., Balogun, F., Hughes, L., Leedom, T. P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/380314 · Cited by 345
Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome
Groesser, L., Herschberger, E., Ruetten, A., Ruivenkamp, C., Lopriore, E., Zutt, M., Langmann, T., Singer, S., Klingseisen, L., Schneider-Brachert, W., et al. (2012) · Nature Genetics · doi:10.1038/ng.2316 · Cited by 335
Cerebral cavernous malformations arise from endothelial gain of MEKK3–KLF2/4 signalling
Zhou, Z., Tang, A. T., Wong, W.-Y., Bamezai, S., Goddard, L. M., Shenkar, R., Zhou, S., Yang, J., Wright, A. C., Foley, M., et al. (2016) · Nature · doi:10.1038/nature17178 · Cited by 332
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
Lindhurst, M. J., Parker, V. E. R., Payne, F., Sapp, J. C., Rudge, S., Harris, J., Witkowski, A. M., Zhang, Q., Groeneveld, M. P., Scott, C. E., et al. (2012) · Nature Genetics · doi:10.1038/ng.2332 · Cited by 325
Self-citationAmyere, M., Revencu, N., Helaers, R., Pairet, E., Baselga, E., Cordisco, M., Chung, W., Dubois, J., Lacour, J.-P., Martorell, L., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026886 · Cited by 302
Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation
Couto, J. A., Huang, A. Y., Konczyk, D. J., Goss, J. A., Fishman, S. J., Mulliken, J. B., Warman, M. L., & Greene, A. K. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.018 · Cited by 298
Revencu, N., Boon, L. M., Mendola, A., Cordisco, M. R., Dubois, J., Clapuyt, P., Hammer, F., Amor, D. J., Irvine, A. D., Baselga, E., et al. (2013) · Human Mutation · doi:10.1002/humu.22431 · Cited by 294
Akers, A. L., Johnson, E., Steinberg, G. K., Zabramski, J. M., & Marchuk, D. A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn430 · Cited by 292
Vascular Development in the Zebrafish
Gore, A. V., Monzo, K., Cha, Y. R., Pan, W., & Weinstein, B. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006684 · Cited by 282
Arteries and veins: making a difference with zebrafish
Lawson, N. D., & Weinstein, B. M. (2002) · Nature Reviews Genetics · doi:10.1038/nrg888 · Cited by 264
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations
Soblet, J., Kangas, J., Nätynki, M., Mendola, A., Helaers, R., Uebelhoer, M., Kaakinen, M., Cordisco, M., Dompmartin, A., Enjolras, O., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.07.034 · Cited by 251
Self-citationMekk3 is essential for early embryonic cardiovascular development
Yang, J., Boerm, M., McCarty, M., Bucana, C., Fidler, I. J., Z J Yang, Y., & Su, B. (2000) · Nature Genetics · doi:10.1038/73550 · Cited by 244
Zhou, X.-P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.5.765 · Cited by 215
Thomas, A. C., Zeng, Z., Rivière, J.-B., O’Shaughnessy, R., Al-Olabi, L., St.-Onge, J., Atherton, D. J., Aubert, H., Bagazgoitia, L., Barbarot, S., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.11.027 · Cited by 195
Self-citationSomatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans
Castillo, S. D., Tzouanacou, E., Zaw-Thin, M., Berenjeno, I. M., Parker, V. E. R., Chivite, I., Milà-Guasch, M., Pearce, W., Solomon, I., Angulo-Urarte, A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9982 · Cited by 192
Self-citationMirzaa, G., Timms, A. E., Conti, V., Boyle, E. A., Girisha, K. M., Martin, B., Kircher, M., Olds, C., Juusola, J., Collins, S., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87623 · Cited by 185
Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors
Fischmann, T. O., Smith, C. K., Mayhood, T. W., Myers, J. E., Reichert, P., Mannarino, A., Carr, D., Zhu, H., Wong, J., Yang, R.-S., et al. (2009) · Biochemistry · doi:10.1021/bi801898e · Cited by 183
A Somatic MAP3K3 Mutation Is Associated with Verrucous Venous Malformation
Couto, J. A., Vivero, M. P., Kozakewich, H. P., Taghinia, A. H., Mulliken, J. B., Warman, M. L., & Greene, A. K. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.01.007 · Cited by 149
BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma
Groesser, L., Peterhof, E., Evert, M., Landthaler, M., Berneburg, M., & Hafner, C. M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.376 · Cited by 128
Somatic Uniparental Isodisomy Explains Multifocality of Glomuvenous Malformations
Amyere, M., Aerts, V., Brouillard, P., McIntyre, B. A. S., Duhoux, F. P., Wassef, M., Enjolras, O., Mulliken, J. B., Devuyst, O., Poirel, H. A., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.12.017 · Cited by 122
Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway
Nathan, N. R., Keppler‐Noreuil, K. M., Biesecker, L. G., Moss, J., & Darling, T. N. (2016) · Dermatologic Clinics · doi:10.1016/j.det.2016.07.001 · Cited by 120
Self-citationShenkar, R., Shi, C., Austin, C., Moore, T., Lightle, R., Cao, Y. J., Zhang, L., Wu, M., Zeineddine, H. A., Girard, R., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.015013 · Cited by 107
Structure and vascular function of MEKK3–cerebral cavernous malformations 2 complex
Fisher, O. S., Deng, H., Liu, D., Zhang, Y., Rong, W., Deng, Y., Zhang, F., Louvi, A., Turk, B. E., Boggon, T. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8937 · Cited by 104
Anastasaki, C., Estep, A. L., Marais, R., Rauen, K. A., & Patton, E. E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp186 · Cited by 96
Self-citationThe pathobiology of vascular malformations: insights from human and model organism genetics
Wetzel‐Strong, S. E., Detter, M. R., & Marchuk, D. A. (2016) · The Journal of Pathology · doi:10.1002/path.4844 · Cited by 89
Culleré, X., Plovie, E. R., Bennett, P. M., MacRae, C. A., & Mayadas, T. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510495112 · Cited by 81
Boppudi, S., Bögershausen, N., Hove, H., Perçin, E. F., Aslan, D., Dvorský, R., Kayhan, G., Li, Y., Cursiefen, C., Tantcheva‐Poór, I., et al. (2016) · Clinical Genetics · doi:10.1111/cge.12775 · Cited by 77
Mosaic Activating RAS Mutations in Nevus Sebaceus and Nevus Sebaceus Syndrome
Sun, B. K., Saggini, A., Sarin, K. Y., Kim, J., Benjamin, L., LeBoit, P. E., & Khavari, P. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.377 · Cited by 67
Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutation
Gripp, K. W., Baker, L., Kandula, V. V. R., Conard, K. A., Scavina, M. T., Napoli, J. A., Griffin, G. C., Thacker, M. M., Knox, R. G., Clark, G. R., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37758 · Cited by 63
Self-citationContinual and partial MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish
Anastasaki, C., Rauen, K. A., & Patton, E. E. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008672 · Cited by 60
Self-citationOculoectodermal syndrome is a mosaic RASopathy associated with KRAS alterations
Peacock, J. D., Dykema, K. J., Toriello, H. V., Mooney, M. R., Scholten, D. J., Winn, M. E., Borgman, A. S., Duesbery, N. S., Hiemenga, J. A., Liu, C., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37048 · Cited by 58
Farschtschi, S. C., Mautner, V., Hollants, S., Hagel, C., Spaepen, M., Schulte, C., Legius, E., & Brems, H. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0146-5 · Cited by 31
KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant
Wang, H., Qian, Y., Wu, B., Zhang, P., & Zhou, W. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0247-1 · Cited by 27
Cited by
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials
Patton, E. E., Zon, L. I., & Langenau, D. M. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00210-8 · Cited by 567
Self-citationRepurposing drugs to treat cardiovascular disease in the era of precision medicine
Abdelsayed, M., Kort, E. J., Jovinge, S., & Mercola, M. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00717-6 · Cited by 93
“Similar zebrafish models of arteriovenous malformations caused by variants in BRAF or MAP2K1 (which act upstream in the RAF–RAS–MAPK cascade) provided proof- of-concept that vemurafenib, a BRAF inhibitor, could improve blood flow, mimicking results seen in mouse models 99 .”
ResultGermline and sporadic cancers driven by the RAS pathway: parallels and contrasts
Dunnett-Kane, V., Burkitt-Wright, E., Blackhall, F. H., Malliri, A., Evans, D. G., & Lindsay, C. R. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.291 · Cited by 66
Kapp, F. G., Bazgir, F., Mahammadzade, N., Mehrabipour, M., Vassella, E., Bernhard, S. M., Döring, Y., Holm, A., Karow, A., Seebauer, C., et al. (2024) · Angiogenesis · doi:10.1007/s10456-024-09934-8 · Cited by 20
Metadata
- Authors
- Al-Olabi, L., Polubothu, S., Dowsett, K., Andrews, K. A., Stadnik, P., Joseph, A. P., Knox, R., Pittman, A., Clark, G., Baird, W., Bulstrode, N., Glover, M., Gordon, K., Hargrave, D., Huson, S. M., Jacques, T. S., James, G., Kondolf, H., Kangesu, L., Keppler-Noreuil, K. M., Khan, A., Lindhurst, M. J., Lipson, M., Mansour, S., O’Hara, J., Mahon, C., Mosica, A., Moss, C., Murthy, A., Ong, J., Parker, V. E., Rivière, J.-B., Sapp, J. C., Sebire, N. J., Shah, R., Sivakumar, B., Thomas, A., Virasami, A., Waelchli, R., Zeng, Z., Biesecker, L. G., Barnacle, A., Topf, M., Semple, R. K., Patton, E. E., & Kinsler, V. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2018-03-12
- Volume
- 128
- Issue
- 4
- Pages
- 1496-1508
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2788648365
- Cited by
- 292
- References
- 48
- FWCI
- 26.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.